Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015; 16 (1): 45-56. doi:10.1038/ni.3049.
Loddenkemper R, Gibson GJ, Sibille Y. The burden of lung disease in Europe: why a European White Book on lung disease? Eur Respir J. 2003; 22 (6): 869. doi:10.1183/09031936.03.00107803.
Lo CY, Michaeloudes C, Bhavsar PK, et al. Increased phenotypic differentiation and reduced corticosteroid sensitivity of fibrocytes in severe asthma. J Allergy Clin Immunol. 2015; 135 (5): 1186-1195.e1-6. doi:10.1016/j.jaci.2014.10.031.
Kim RY, Rae B, Neal R, et al. Elucidating novel disease mechanisms in severe asthma. Clin Transl Immunology. 2016; 5 (7): e91. doi:10.1038/cti.2016.37.
Clemmer GL, Wu AC, Rosner B, et al. Measuring the corticosteroid responsiveness endophenotype in asthmatic patients. J Allergy Clin Immunol. 2015; 136 (2): 274-281.e8. doi:10.1016/j.jaci.2015.03.029.
Choy DF, Hart KM, Borthwick LA, et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med. 2015; 7 (301): 301ra129. doi:10.1126/scitranslmed.aab3142.
Gauthier M, Chakraborty K, Oriss TB, et al. Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias. JCI Insight. 2017; 2 (13): e94580. doi:10.1172/jci.insight.94580.
Kulikov YeS, Ogorodova LM, Freidin MB, et al. Gene expression dynamics in patients with severe therapy-resistant asthma during treatment period. BSM. 2014; 13 (1): 47-55. (In Russ).
Miyaji M, Kortum RL, Surana R, et al. Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice. Proc Natl Acad Sci U S A. 2009; 106 (34): 14502-14507. doi:10.1073/pnas.0903894106.
Li CY, Peng J, Ren LP, et al. Roles of histone hypoacetylation in LAT expression on T cells and Th2 polarization in allergic asthma. J Transl Med. 2013; 11: 26. doi: 10.1186/1479-5876-11-26.
Kunii N, Zhao Y, Jiang S, et al. Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation. Hum Gene Ther. 2013; 24 (1): 27-37. doi:10.1089/hum.2012.130.
Guo XJ, Li J, Ni PH, et al. [The transcription levels of linker for activation of T cell and its upstream regulatory factors in T cells of asthmatic patients. (In Chinese). Zhonghua Jie He He Hu Xi Za Zhi. 2008; 31 (2): 125-128.
Szczepankiewicz A, Sobkowiak P, Rachel M, et al. Multilocus analysis of candidate genes involved in neurogenic inflammation in pediatric asthma and related phenotypes: a case-control study. J Asthma. 2012; 49 (4): 329-335. doi:10.3109/02770903.2012.669442.
Chikanza IC, Kozaci D, Chernajovsky Y. The molecular and cellular basis of corticosteroid resistance. J Endocrinol. 2003; 179 (3): 301-310. doi:10.1677/joe.0.1790301.
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med. 2000; 162 (6): 2341-2351. doi:10.1164/ajrccm.162.6.ats9-00
R Core Team (2016) [Internet]. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: https://www.r-project.org/
Oksanen J, Blanchet FG, Friendly M, et al. Ordination methods, diversity analysis and other functions for community and vegetation ecologists [Internet]. Vegan: Community Ecology Package; 2017 [cited 2018 Jul 29]. Available from: https://CRAN.R-project.org/package=vegan.
Wickham H. ggplot2: elegant graphics for data analysis. New York, USA: Springer-Verlag New York; 2009. 213 p. doi:10.1007/978-0-387-98141-3.
Goleva E, Li LB, Leung DY. IFN-gamma reverses IL-2 and IL-4-mediated T-cell steroid resistance. Am J Respir Cell Mol Biol. 2009; 40 (2): 223-230. doi:10.1165/rcmb.2007-0327OC.
Liang Q, Guo L, Gogate S, et al. IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma. J Immunol. 2010; 185 (10): 5704-5713. doi:10.4049/jimmunol.1000690.
Laurenzana I, Caivano A, Trino S, et al. A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia. Oncotarget. 2016; 7 (40): 65171-65184. doi:10.18632/oncotarget.11496.
Brunetti M, Martelli N, Colasante A, et al. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood. 1995; 86 (11): 4199-4205.
Xie H, Seward RJ, Huber BT. Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IkappaBalpha. Mol Immunol. 1997; 34 (14): 987-994. doi:10.1016/s0161-5890(97)00128-4.
Pazdrak K, Straub C, Maroto R, et al. Cytokine-induced gluco-corticoid resistance from eosinophil activation: protein phospha-tase 5 modulation of glucocorticoid receptor phosphorylation and signaling. J Immunol. 2016; 197 (10): 3782-3791. doi:10.4049/jim-munol.1601029.
Pace E, Gagliardo R, Melis M, et al. Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. J Allergy Clin Immunol. 2004; 114 (5): 1216-1223. doi:10.1016/j.jaci.2004.07.052.